CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.
Show more...
CEO
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
The current price of CEVI.ST is SEK153.6 SEK — it has increased by +1.99% in the past 24 hours. Watch Cellavision AB stock price performance more closely on the chart.
What is Cellavision AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellavision AB stocks are traded under the ticker CEVI.ST.
Is Cellavision AB stock price growing?▼
CEVI.ST stock has risen by +5.06% compared to the previous week, the month change is a +1.19% rise, over the last year Cellavision AB has showed a -9.75% decrease.
What is Cellavision AB market cap?▼
Today Cellavision AB has the market capitalization of 3.66B
When is the next Cellavision AB earnings date?▼
Cellavision AB is going to release the next earnings report on April 24, 2026.
What were Cellavision AB earnings last quarter?▼
CEVI.ST earnings for the last quarter are 1.76 SEK per share, whereas the estimation was 1.28 SEK resulting in a +37.28% surprise. The estimated earnings for the next quarter are N/A SEK per share.
What is Cellavision AB revenue for the last year?▼
Cellavision AB revenue for the last year amounts to 1.45B SEK.
What is Cellavision AB net income for the last year?▼
CEVI.ST net income for the last year is 281.44M SEK.
Does Cellavision AB pay dividends?▼
Yes, CEVI.ST dividends are paid annual. The last dividend per share was 2.5 SEK. As of today, Dividend Yield (FWD)% is 1.79%.
How many employees does Cellavision AB have?▼
As of April 01, 2026, the company has 229 employees.
In which sector is Cellavision AB located?▼
Cellavision AB operates in the Health Care sector.
When did Cellavision AB complete a stock split?▼
Cellavision AB has not had any recent stock splits.